Skip to main content
. 2011 Aug 8;589(Pt 19):4671–4679. doi: 10.1113/jphysiol.2011.216218

Figure 3. Percentage maximal skin blood flow (SkBF) with infusion of 500 nm of ET-A receptor antagonist [BQ-123] (left) or 300 nm of ET-B receptor antagonist [BQ-788] (right) via microdialysis in women with (PCOS) and without (Control) polycystic ovary syndrome.

Figure 3

*Different between PCOS and Control. Data are presented as means ± SEM.